Summary

for people ages 4-17 (full criteria)
study started
estimated completion:
Amy Gelfand

Description

Summary

This is a multi-center registry that will prospectively collect regulatory compliant data from children and adolescents with migraine. This study will enroll approximately 200 participants from approximately 20 sites and will examine migraine symptoms, therapeutics used, and biomarkers associated with migraine.

Official Title

Observational Study of Pediatric Migraine: The Pediatric Migraine Registry

Keywords

Migraine Migraine Disorders

Eligibility

You can join if…

Open to people ages 4-17

  • 4 to 17 years of age inclusive at the time of enrollment visit
  • Meets International Classification of Headache Disorders, 3rd edition criteria for migraine with or without aura
  • Guardian provides informed consent/HIPAA
  • Participant provides assent if developmentally appropriate and required by the institutional review board

You CAN'T join if...

  • Any condition which would make the participant, in the opinion of the investigator,unsuitable for the study

Lead Scientist

  • Amy Gelfand
    Dr. Amy Gelfand is a board-certified child neurologist and Director of Pediatric Headache at UCSF. She specializes in diagnosing and treating children who suffer from a variety of headache disorders, as well as children with childhood periodic syndromes such as abdominal migraine that may be precursors to migraine headache later in life.

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
Duke University
ID
NCT03742024
Study Type
Observational [Patient Registry]
Last Updated